SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-019506
Filing Date
2023-07-06
Accepted
2023-07-06 17:00:31
Documents
13
Period of Report
2023-06-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20230629_8k.htm   iXBRL 8-K 20558
  Complete submission text file 0001437749-23-019506.txt   150722

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nby-20230629.xsd EX-101.SCH 3400
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20230629_def.xml EX-101.DEF 11420
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20230629_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20230629_pre.xml EX-101.PRE 11580
7 EXTRACTED XBRL INSTANCE DOCUMENT nby20230629_8k_htm.xml XML 2565
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 231074260
SIC: 2834 Pharmaceutical Preparations